Copyright Reports & Markets. All rights reserved.

Global Artificial Blood Market Insights, Forecast to 2025

Request for Sample of this report
Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Artificial Blood Industry
  • 1.7 COVID-19 Impact: Artificial Blood Market Trends

    • 2 Global Artificial Blood Quarterly Market Size Analysis

    • 2.1 Artificial Blood Business Impact Assessment - COVID-19
      • 2.1.1 Global Artificial Blood Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Artificial Blood Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 By Players, Global Artificial Blood Quarterly Market Size, 2019 VS 2020
    • 3.2 By Players, Artificial Blood Headquarters and Area Served
    • 3.3 Date of Key Players Enter into Artificial Blood Market
    • 3.4 Key Players Artificial Blood Product Offered
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Artificial Blood Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Human Blood
      • 1.4.2 Synthetic Blood
      • 1.4.3 Animal Blood
    • 4.2 By Type, Global Artificial Blood Market Size, 2019-2021

    5 Impact of Covid-19 on Artificial Blood Segments, By Application

    • 5.1 Overview
      • 5.5.1 Hemoglobin-Based Oxygen Carriers (HBOCs)
      • 5.5.2 Perflurocarbon Emulsions (PFCEs)
    • 5.2 By Application, Global Artificial Blood Market Size, 2019-2021
      • 5.2.1 By Application, Global Artificial Blood Market Size by Application, 2019-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Dextro-Sang Corporation
      • 7.1.1 Dextro-Sang Corporation Business Overview
      • 7.1.2 Dextro-Sang Corporation Artificial Blood Quarterly Revenue, 2020
      • 7.1.3 Dextro-Sang Corporation Artificial Blood Product Introduction
      • 7.1.4 Dextro-Sang Corporation Response to COVID-19 and Related Developments
    • 7.2 BioPure Corporation
      • 7.2.1 BioPure Corporation Business Overview
      • 7.2.2 BioPure Corporation Artificial Blood Quarterly Revenue, 2020
      • 7.2.3 BioPure Corporation Artificial Blood Product Introduction
      • 7.2.4 BioPure Corporation Response to COVID-19 and Related Developments
    • 7.3 Sangart
      • 7.3.1 Sangart Business Overview
      • 7.3.2 Sangart Artificial Blood Quarterly Revenue, 2020
      • 7.3.3 Sangart Artificial Blood Product Introduction
      • 7.3.4 Sangart Response to COVID-19 and Related Developments
    • 7.4 Northfield Laboratories
      • 7.4.1 Northfield Laboratories Business Overview
      • 7.4.2 Northfield Laboratories Artificial Blood Quarterly Revenue, 2020
      • 7.4.3 Northfield Laboratories Artificial Blood Product Introduction
      • 7.4.4 Northfield Laboratories Response to COVID-19 and Related Developments
    • 7.5 Baxter International
      • 7.5.1 Baxter International Business Overview
      • 7.5.2 Baxter International Artificial Blood Quarterly Revenue, 2020
      • 7.5.3 Baxter International Artificial Blood Product Introduction
      • 7.5.4 Baxter International Response to COVID-19 and Related Developments
    • 7.6 Dentritech
      • 7.6.1 Dentritech Business Overview
      • 7.6.2 Dentritech Artificial Blood Quarterly Revenue, 2020
      • 7.6.3 Dentritech Artificial Blood Product Introduction
      • 7.6.4 Dentritech Response to COVID-19 and Related Developments
    • 7.7 FluorO2 Therapeutics
      • 7.7.1 FluorO2 Therapeutics Business Overview
      • 7.7.2 FluorO2 Therapeutics Artificial Blood Quarterly Revenue, 2020
      • 7.7.3 FluorO2 Therapeutics Artificial Blood Product Introduction
      • 7.7.4 FluorO2 Therapeutics Response to COVID-19 and Related Developments
    • 7.8 Nuvox Pharma
      • 7.8.1 Nuvox Pharma Business Overview
      • 7.8.2 Nuvox Pharma Artificial Blood Quarterly Revenue, 2020
      • 7.8.3 Nuvox Pharma Artificial Blood Product Introduction
      • 7.8.4 Nuvox Pharma Response to COVID-19 and Related Developments
    • 7.9 Alpha Therapeutic Corporation
      • 7.9.1 Alpha Therapeutic Corporation Business Overview
      • 7.9.2 Alpha Therapeutic Corporation Artificial Blood Quarterly Revenue, 2020
      • 7.9.3 Alpha Therapeutic Corporation Artificial Blood Product Introduction
      • 7.9.4 Alpha Therapeutic Corporation Response to COVID-19 and Related Developments
    • 7.10 HemoBioTech
      • 7.10.1 HemoBioTech Business Overview
      • 7.10.2 HemoBioTech Artificial Blood Quarterly Revenue, 2020
      • 7.10.3 HemoBioTech Artificial Blood Product Introduction
      • 7.10.4 HemoBioTech Response to COVID-19 and Related Developments

    8 Key Findings

      9 Appendix

      • 9.1 About US

      This report covers market size and forecasts of Artificial Blood, including the following market information:
      Global Artificial Blood Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Artificial Blood Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Artificial Blood Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Artificial Blood Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)

      Key market players
      Major competitors identified in this market include Dextro-Sang Corporation, BioPure Corporation, Sangart, Northfield Laboratories, Baxter International, Dentritech, FluorO2 Therapeutics, Nuvox Pharma, Alpha Therapeutic Corporation, HemoBioTech, etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      Human Blood
      Synthetic Blood
      Animal Blood

      Based on the Application:
      Hemoglobin-Based Oxygen Carriers (HBOCs)
      Perflurocarbon Emulsions (PFCEs)

      Buy now